CORC

在结果中检索

CORC

浏览/检索结果: 共98条，第1-10条 帮助

限定条件    
已选(0)清除 条数/页：   排序方式：
Remodeling Tumor-Associated Macrophages and Neovascularization Overcomes EGFR(T790M)-Associated Drug Resistance by PD-L1 Nanobody-Mediated Codelivery 期刊论文
SMALL, 2018, 卷号: 14, 期号: 47
作者:  Yin, Weimin;  Yu, Xiaolu;  Kang, Xuejia;  Zhao, Yuge;  Zhao, Pengfei
收藏  |  浏览/下载：100/0  |  提交时间：2019/01/08
Suppressor of cytokine signalling-2 limits igf1r-mediated regulation of epithelial-mesenchymal transition in lung adenocarcinoma 期刊论文
Cell death & disease, 2018, 卷号: 9, 页码: 14
作者:  Zhou, Yue;  Zhang, Zhilei;  Wang, Ning;  Chen, Jizheng;  Zhang, Xu
收藏  |  浏览/下载：78/0  |  提交时间：2019/05/08
Impact of menopausal status and HER-2/neu protein on efficacy of EGFR-TKI in EGFR mutant patients with non-small cell lung cancer 期刊论文
JOURNAL OF CANCER, 2018
作者:  Yin, Zi-Jun;  Tu, Hai-Yan;  Fu, Ming;  Zhong, Wen-Zhao;  An, She-Juan
收藏  |  浏览/下载：22/0  |  提交时间：2019/01/31
Clinical efficacy of bevacizumab combined with gemcitabine and cisplatin combination chemotherapy in the treatment of advanced non-small cell lung cancer 期刊论文
JOURNAL OF BUON, 2018, 卷号: 23, 期号: 5
作者:  Duan, Jianchun;  Yang, Zhenhua;  Liu, Dingyuan;  Zhang, Zhen;  Shi, Yunfei
收藏  |  浏览/下载：10/0  |  提交时间：2019/12/04
Afatinib versus gemcitabine/cisplatin for first-line treatment of Chinese patients with advanced non-small-cell lung cancer harboring EGFR mutations: subgroup analysis of the LUX-Lung 6 trial 期刊论文
ONCOTARGETS AND THERAPY, 2018, 卷号: 11
作者:  Wu, Yi-Long;  Xu, Chong-Rui;  Hu, Cheng-Ping;  Feng, Jifeng;  Lu, Shun
收藏  |  浏览/下载：16/0  |  提交时间：2019/12/04
Effect of Anlotinib as a Third-Line or Further Treatment on Overall Survival of Patients With Advanced Non-Small Cell Lung Cancer The ALTER 0303 Phase 3 Randomized Clinical Trial 期刊论文
JAMA ONCOLOGY, 2018, 卷号: 4, 期号: 11
作者:  Han, Baohui;  Li, Kai;  Wang, Qiming;  Zhang, Li;  Shi, Jianhua
收藏  |  浏览/下载：3/0  |  提交时间：2019/12/04
Does EGFR Mutation Type Influence Patient-Reported Outcomes in Patients with Advanced EGFR Mutation-Positive Non-Small-Cell Lung Cancer? Analysis of Two Large, Phase III Studies Comparing Afatinib with Chemotherapy (LUX-Lung 3 and LUX-Lung 6) 期刊论文
PATIENT-PATIENT CENTERED OUTCOMES RESEARCH, 2018, 卷号: 11, 期号: 1
作者:  Wu, Yi-Long;  Hirsh, Vera;  Sequist, Lecia V.;  Hu, Cheng-Ping;  Feng, Jifeng
收藏  |  浏览/下载：11/0  |  提交时间：2019/12/04
Association of Base Excision Repair Gene Polymorphisms with the Response to Chemotherapy in Advanced Non-Small Cell Lung Cancer 期刊论文
CHINESE MEDICAL JOURNAL, 2018, 卷号: 131, 期号: 16
作者:  Dong, Jie;  Wang, Xu;  Yu, Yu;  Yan, Xu;  Cui, Jiu-Wei
收藏  |  浏览/下载：9/0  |  提交时间：2019/12/05
Afatinib versus gemcitabine/cisplatin for first-line treatment of Chinese patients with advanced non-small-cell lung cancer harboring EGFR mutations: subgroup analysis of the LUX-Lung 6 trial 期刊论文
ONCOTARGETS AND THERAPY, 2018, 卷号: 11
作者:  Lu, Shun;  Wu, Yi-Long;  Huang, Yunchao;  Hu, Cheng-Ping;  Li, Wei
收藏  |  浏览/下载：17/0  |  提交时间：2019/12/05
Mutation status and targeted therapeutic efficacy of advanced non-small cell lung cancer: A real-world study of NSCLC in China (preCAPTRA-LUNG) 会议论文
作者:  Liang, H.;  Song, X.;  Zhang, Y.;  Zhang, S.;  Li, F.
收藏  |  浏览/下载：2/0  |  提交时间：2019/12/05

©版权所有 ©2017 CSpace - Powered by CSpace